Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Pharmaceutical
• Feed additive
• Biologicals
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Growing animal healthcare awareness
• Increasing M&A activity
• Increase in consumer preference towards protein-rich food

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bayer
• Boehringer Ingelheim
• Eli Lilly
• Merck
• Zoetis
• Other prominent vendors
• List of abbreviations

[List of Exhibits]
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition – Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global – Market size and forecast 2017-2022 ($ bn)
Exhibit 08: Global – Year over year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2017
Exhibit 17: Product – Market share 2017-2022 (%)
Exhibit 18: Comparison by product
Exhibit 19: Pharmaceutical – Market size and forecast 2017-2022 ($ bn)
Exhibit 20: Pharmaceutical – Year over year growth 2018-2022 (%)
Exhibit 21: Feed additive – Market size and forecast 2017-2022 ($ bn)
Exhibit 22: Feed additive – Year over year growth 2018-2022 (%)
Exhibit 23: Biologicals- Market size and forecast 2017-2022 ($ bn)
Exhibit 24: Biologicals– Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global – Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 30: Americas – Year over year growth 2018-2022 (%)
Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 32: EMEA – Year over year growth 2018-2022 (%)
Exhibit 33: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 34: APAC – Year over year growth 2018-2022 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Diseases caused by animals and their mode of transmission to humans
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Vendor overview
Exhibit 44: Bayer – Business segments
Exhibit 45: Bayer – Organizational developments
Exhibit 46: Bayer – Geographic focus
Exhibit 47: Bayer – Segment focus
Exhibit 48: Bayer – Key offerings
Exhibit 49: Vendor overview
Exhibit 50: Boehringer Ingelheim– Business segments
Exhibit 51: Boehringer Ingelheim – Organizational developments
Exhibit 52: Boehringer Ingelheim– Geographic focus
Exhibit 53: Boehringer Ingelheim– Segment focus
Exhibit 54: Boehringer Ingelheim– Key offerings
Exhibit 55: Vendor overview
Exhibit 56: Eli Lilly– Business segments
Exhibit 57: Eli Lilly– Organizational developments
Exhibit 58: Eli Lilly– Geographic focus
Exhibit 59: Eli Lilly– Segment focus
Exhibit 60: Eli Lilly– Key offerings
Exhibit 61: Vendor overview
Exhibit 62: Merck– Business segments
Exhibit 63: Merck– Organizational developments
Exhibit 64: Merck– Geographic focus
Exhibit 65: Merck– Segment focus
Exhibit 66: Merck– Key offerings
Exhibit 67: Vendor overview
Exhibit 68: Zoetis– Business segments
Exhibit 69: Zoetis– Organizational developments
Exhibit 70: Zoetis– Geographic focus
Exhibit 71: Zoetis– Segment focus
Exhibit 72: Zoetis– Key offerings